About Wright Medical Group (NASDAQ:WMGI)
Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients' lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Company's business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Company's products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.
Industry, Sector and Symbol
Industry Medical Prosthetics
Sub-IndustryHealth Care Equipment
Trailing P/E Ratio-4.23206751054852
Forward P/E Ratio-74.30
Sales & Book Value
Annual Sales$690.36 million
Price / Sales3.07
Cash Flow$1.19 per share
Price / Cash16.89
Book Value$6.65 per share
Price / Book3.02
Return on Equity-6.27%
Return on Assets-1.71%
Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions
What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
How were Wright Medical Group's earnings last quarter?
Wright Medical Group Inc (NASDAQ:WMGI) posted its quarterly earnings data on Wednesday, November, 1st. The medical device company reported ($0.16) EPS for the quarter, hitting the Zacks' consensus estimate of ($0.16). The medical device company had revenue of $170.50 million for the quarter, compared to the consensus estimate of $173.50 million. Wright Medical Group had a negative return on equity of 6.27% and a negative net margin of 38.40%. The company's quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.19) EPS. View Wright Medical Group's Earnings History.
When will Wright Medical Group make its next earnings announcement?
Where is Wright Medical Group's stock going? Where will Wright Medical Group's stock price be in 2018?
11 brokers have issued 12-month target prices for Wright Medical Group's stock. Their forecasts range from $30.00 to $36.00. On average, they anticipate Wright Medical Group's share price to reach $31.89 in the next twelve months. View Analyst Ratings for Wright Medical Group.
What are Wall Street analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- 1. Needham & Company LLC analysts commented, "WMGI’s 1Q17 revenue and EBITDA missed consensus and management maintained its 2017 guidance. Pro forma revenue growth slowed to 6% CC from 12% CC in 4Q16. The slower growth was due to sales dis-synergies of ~ $5M and disruption from WMGI’s addition of 115 reps in the quarter; however, 1Q17 likely marks the peak for sales dis-synergies and they should begin to decline in 2Q17. Management continues to expect revenue growth to increase from 1H17 to 2H17 due to decreased sales dis-synergies (which are lapped in 2H17), new product launches, and the sales force expansion." (5/4/2017)
- 2. Jefferies Group LLC analysts commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high watermark; and guidance for mid-teens underlying revenue growth supported by numerous product launches. Wright remains exceedingly well positioned and it remains one of our best ideas." (2/22/2017)
- 3. BMO Capital Markets analysts commented, "WMGI reported revenue of $193M (up 16%; up 12% adjusted), nicely ahead of the Street's $183.4 million, including: Lower Extremities up 7% adjusted; Upper Extremities up 15%; Biologics up 28%; and Sports Medicine up 5%. With the integration of Tornier largely in the rear-view mirror, adjusted EBITDA increased meaningfully to $22.7 million from $9.3 million y/y, as management is benefiting from cost synergies that were obtained earlier than expected and better-than-expected revenue. Combined, the result was non-GAAP EPS loss of $0.06 versus the Street's loss of $0.11." (2/22/2017)
Who are some of Wright Medical Group's key competitors?
Some companies that are related to Wright Medical Group include Primary Health Care (PRY), Supernus Pharmaceuticals (SUPN), Auxilium Pharmaceuticals (AUXL), Ignyta (RXDX), Intrexon (XON), Spectranetics (SPNC), Sirtex Medical (SRX), Tivity Health (TVTY), Examworks Group (EXAM), Zogenix (ZGNX), Varex Imaging (VREX), Clinigen Group (CLIN), TherapeuticsMD (TXMD), Zai Lab (ZLAB), Affymetrix (AFFX), Intersect ENT (XENT), ProMetic Life Sciences (PLI) and Athenex (ATNX).
Who owns Wright Medical Group stock?
Wright Medical Group's stock is owned by many different of retail and institutional investors. Top institutional investors include Fisher Asset Management LLC (2.69%), Palo Alto Investors LLC (2.59%), Bridger Management LLC (1.91%), AXA (1.78%), Macquarie Group Ltd. (1.46%) and GW&K Investment Management LLC (1.28%). Company insiders that own Wright Medical Group stock include David D Stevens, David H Mowry, Elizabeth H Weatherman, Gregory Morrison, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Kevin D Cordell, Lance A Berry, Patrick Fisher, Richard F Wallman, Sean Carney and William L Griffin Jr. View Institutional Ownership Trends for Wright Medical Group.
Who sold Wright Medical Group stock? Who is selling Wright Medical Group stock?
Wright Medical Group's stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, OppenheimerFunds Inc., Bridger Management LLC, Renaissance Technologies LLC, Segall Bryant & Hamill LLC, Millennium Management LLC, GW&K Investment Management LLC and Keeley Teton Advisors LLC. Company insiders that have sold Wright Medical Group company stock in the last year include David D Stevens, Gregory Morrison, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Lance A Berry, Patrick Fisher and Richard F Wallman. View Insider Buying and Selling for Wright Medical Group.
Who bought Wright Medical Group stock? Who is buying Wright Medical Group stock?
Wright Medical Group's stock was bought by a variety of institutional investors in the last quarter, including AXA, State of Tennessee Treasury Department, Glenmede Trust Co. NA, Endurant Capital Management LP, Macquarie Group Ltd., Factory Mutual Insurance Co., Comgest Global Investors S.A.S. and Mitsubishi UFJ Asset Management UK Ltd.. View Insider Buying and Selling for Wright Medical Group.
How do I buy Wright Medical Group stock?
Shares of Wright Medical Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Wright Medical Group's stock price today?
One share of Wright Medical Group stock can currently be purchased for approximately $20.06.
How big of a company is Wright Medical Group?
Wright Medical Group has a market capitalization of $1.03 billion and generates $690.36 million in revenue each year. The medical device company earns $-432,370,000.00 in net income (profit) each year or ($4.74) on an earnings per share basis. Wright Medical Group employs 2,394 workers across the globe.
How can I contact Wright Medical Group?
Wright Medical Group's mailing address is 5677 Airline Rd, ARLINGTON, TN 38002-9501, United States. The medical device company can be reached via phone at +1-901-8679971 or via email at [email protected]
MarketBeat Community Rating for Wright Medical Group (WMGI)MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Wright Medical Group (NASDAQ:WMGI) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.73||2.73||2.67||2.64|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$31.89||$31.89||$32.22||$32.25|
|Price Target Upside: ||33.15% upside||33.15% upside||33.98% upside||17.49% upside|
Wright Medical Group (NASDAQ:WMGI) Consensus Price Target History
Wright Medical Group (NASDAQ:WMGI) Analyst Ratings History
(Data available from 2/20/2016 forward)
Wright Medical Group (NASDAQ:WMGI) Earnings History and Estimates Chart
Wright Medical Group (NASDAQ WMGI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/1/2017||Q3 2017||($0.16)||($0.16)||$173.50 million||$170.50 million||View||N/A|
|8/2/2017||6/30/2017||($0.09)||($0.07)||$178.17 million||$179.69 million||View||Listen|
|5/3/2017||3/31/2017||($0.08)||($0.09)||$182.42 million||$177.19 million||View||Listen|
|2/21/2017||Q416||($0.11)||($0.06)||$183.59 million||$193.02 million||View||Listen|
|11/2/2016||Q316||($0.20)||($0.19)||$157.64 million||$157.30 million||View||N/A|
|8/2/2016||Q216||($0.22)||($0.11)||$172.81 million||$170.00 million||View||N/A|
|5/4/2016||Q116||($0.25)||($0.06)||$170.95 million||$181.02 million||View||N/A|
|2/23/2016||Q415||($0.33)||($0.08)||$165.99 million||$177.00 million||View||Listen|
|11/4/2015||Q315||($0.42)||($0.51)||$78.10 million||$80.14 million||View||Listen|
|8/5/2015||Q2||($0.14)||($0.19)||$85.16 million||$83.22 million||View||N/A|
|7/29/2015||Q2||($0.48)||($0.53)||$77.55 million||$80.42 million||View||Listen|
|5/5/2015||($0.05)||($0.07)||$90.20 million||$88.09 million||View||N/A|
|4/29/2015||Q115||($0.45)||($0.51)||$74.98 million||$77.90 million||View||Listen|
|2/25/2015||Q414||($0.27)||($0.25)||$84.10 million||$83.30 million||View||Listen|
|2/24/2015||($0.12)||($0.06)||$90.73 million||$92.40 million||View||N/A|
|11/6/2014||Q3 14||($0.19)||($0.20)||$76.70 million||$76.70 million||View||N/A|
|11/5/2014||Q314||($0.34)||($0.35)||$73.00 million||$71.30 million||View||Listen|
|8/7/2014||Q214||($0.16)||($0.20)||$79.40 million||$86.85 million||View||N/A|
|8/5/2014||Q214||($0.45)||($0.48)||$74.17 million||$72.40 million||View||Listen|
|5/6/2014||Q114||($0.14)||($0.11)||$80.41 million||$89.00 million||View||N/A|
|4/30/2014||Q114||($0.42)||($0.34)||$69.49 million||$71.10 million||View||Listen|
|2/24/2014||Q413||($0.18)||($0.17)||$64.98 million||$67.80 million||View||Listen|
|2/20/2014||Q413||($0.15)||($0.22)||$76.21 million||$83.40 million||View||N/A|
|11/5/2013||Q313||($0.14)||($0.18)||$70.64 million||$66.70 million||View||N/A|
|11/4/2013||Q313||($0.18)||($0.18)||$56.30 million||$57.64 million||View||Listen|
|8/6/2013||Q2 2013||($0.14)||($0.28)||$77.20 million||$78.10 million||View||N/A|
|8/5/2013||Q2 2013||($0.13)||($0.13)||$122.55 million||$60.60 million||View||Listen|
|5/7/2013||Q1 2013||($0.10)||($0.17)||$81.61 million||$82.70 million||View||N/A|
|4/30/2013||Q1 2013||($0.05)||($0.02)||$121.42 million||$120.40 million||View||Listen|
|2/21/2013||Q4 2012||($0.02)||$0.01||$120.93 million||$123.50 million||View||Listen|
|2/21/2013||Q4 2012||($0.06)||($0.02)||$77.31 million||$79.00 million||View||N/A|
|11/5/2012||Q312||($0.08)||($0.13)||$58.07 million||$58.00 million||View||N/A|
|11/5/2012||Q312||($0.05)||$0.01||$110.87 million||$110.40 million||View||N/A|
Wright Medical Group (NASDAQ:WMGI) Earnings Estimates
2018 EPS Consensus Estimate: $0.02
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Wright Medical Group (NASDAQ:WMGI)
No dividend announcements for this company have been tracked by MarketBeat.com
Wright Medical Group (NASDAQ WMGI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.50%
Wright Medical Group (NASDAQ WMGI) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/9/2018||Patrick Fisher||Insider||Sell||100||$20.14||$2,014.00|| |
|1/12/2018||Patrick Fisher||Insider||Sell||100||$24.41||$2,441.00|| |
|12/15/2017||Patrick Fisher||Insider||Sell||100||$22.80||$2,280.00|| |
|11/17/2017||Patrick Fisher||Insider||Sell||100||$24.36||$2,436.00|| |
|11/13/2017||Gregory Morrison||SVP||Sell||92,140||$23.70||$2,183,718.00|| |
|11/10/2017||Richard F Wallman||Director||Buy||4,000||$24.00||$96,000.00|| |
|10/20/2017||Patrick Fisher||Insider||Sell||100||$26.69||$2,669.00|| |
|9/18/2017||Patrick Fisher||Insider||Sell||100||$26.77||$2,677.00|| |
|7/19/2017||Jennifer S. Walker||SVP||Sell||20,000||$28.00||$560,000.00|| |
|6/9/2017||Jennifer S. Walker||SVP||Sell||10,000||$26.77||$267,700.00|| |
|6/2/2017||Jonathan Wesley Porter||SVP||Sell||2,490||$27.09||$67,454.10|| |
|6/2/2017||Julie Andrews||VP||Sell||1,480||$27.11||$40,122.80|| |
|6/2/2017||Lance A. Berry||Insider||Sell||6,685||$27.14||$181,430.90|| |
|3/6/2017||John L. Miclot||Director||Sell||20,618||$28.50||$587,613.00|| |
|2/27/2017||David D. Stevens||Director||Sell||11,807||$28.01||$330,714.07|| |
|2/22/2017||Richard F. Wallman||Director||Sell||16,375||$28.25||$462,593.75|| |
|2/8/2017||Richard F. Wallman||Director||Sell||9,000||$26.25||$236,250.00|| |
|1/10/2017||Richard F. Wallman||Director||Sell||9,000||$25.25||$227,250.00|| |
|12/8/2016||Elizabeth H. Weatherman||Director||Sell||44,012||$23.80||$1,047,485.60|| |
|12/1/2016||Sean Carney||Director||Sell||54,748||$22.82||$1,249,349.36|| |
|8/3/2016||Patrick Fisher||Insider||Sell||1,000||$25.00||$25,000.00|| |
|6/2/2016||Julie Andrews||CAO||Sell||961||$19.33||$18,576.13||21,179|| |
|6/2/2016||Kevin D Cordell||Insider||Sell||1,652||$19.34||$31,949.68||27,475|| |
|6/2/2016||Lance A Berry||CFO||Sell||4,432||$19.40||$85,980.80||94,123|| |
|6/2/2016||William L Griffin Jr||SVP||Sell||734||$19.33||$14,188.22||75,678|| |
|5/27/2016||Sean Carney||Director||Sell||6,221,809||$18.39||$114,419,067.51||32,814|| |
|3/7/2016||David H Mowry||COO||Sell||13,500||$17.35||$234,225.00||160,311|| |
|10/7/2015||Julie Andrews||VP||Sell||2,694||$20.37||$54,876.78||12,260|| |
|10/7/2015||Kevin D. Cordell||insider||Sell||1,778||$20.37||$36,217.86||5,924|| |
|10/7/2015||Lance A. Berry||CFO||Sell||5,146||$20.37||$104,824.02||57,950|| |
|10/7/2015||William L. Griffin, Jr.||SVP||Sell||3,405||$20.37||$69,359.85||67,721|| |
|10/2/2015||Lance A. Berry||CFO||Sell||5,669||$21.19||$120,126.11||63,096|| |
|5/15/2015||Julie D Tracy||SVP||Sell||1,120||$26.10||$29,232.00|| |
|5/15/2015||Lance A Berry||CFO||Sell||1,675||$26.13||$43,767.75|| |
|5/15/2015||Pascal E R Girin||COO||Sell||3,821||$26.13||$99,842.73|| |
|5/12/2015||Lance A Berry||CFO||Sell||2,320||$25.34||$58,788.80|| |
|5/12/2015||Stephan Epinette||VP||Sell||62,666||$25.00||$1,566,650.00|| |
|5/12/2015||William L Griffin Jr||SVP||Sell||2,452||$25.35||$62,158.20|| |
|4/2/2015||Lance A Berry||CFO||Sell||47,966||$25.75||$1,235,124.50|| |
|1/21/2015||Richard B Emmitt||Director||Sell||7,413||$24.72||$183,249.36|| |
|1/14/2015||Richard B Emmitt||Director||Sell||23,992||$25.05||$600,999.60|| |
|8/14/2014||Stephan Epinette||VP||Sell||2,500||$22.00||$55,000.00|| |
|6/3/2014||David H Mowry||CEO||Sell||5,850||$21.49||$125,716.50|| |
|6/3/2014||Shawn Mccormick||CFO||Sell||2,870||$21.42||$61,475.40|| |
|6/3/2014||Terry Rich||SVP||Sell||4,300||$21.45||$92,235.00|| |
|6/3/2014||Ummersen Gordon Van||VP||Sell||1,660||$21.51||$35,706.60|| |
|5/15/2014||Eric Stookey||Insider||Sell||2,138||$29.23||$62,493.74||85,262|| |
|5/15/2014||Lance Berry||CFO||Sell||2,135||$29.30||$62,555.50||68,665|| |
|5/15/2014||William Griffin, Jr.||SVP||Sell||2,106||$29.36||$61,832.16||72,643|| |
|5/12/2014||Eric Stookey||Insider||Sell||1,978||$29.81||$58,964.18||81,554|| |
|5/12/2014||William Griffin, Jr.||SVP||Sell||2,340||$29.91||$69,989.40||68,886|| |
|3/18/2014||Alain Tornier||Director||Sell||233,210||$20.00||$4,664,200.00||14,062|| |
|3/6/2014||Alain Tornier||Director||Sell||53,288||$20.01||$1,066,292.88||14,062|| |
|3/4/2014||Lance Berry||CFO||Sell||28,370||$33.00||$936,210.00||65,916|| |
|3/4/2014||Richard Emmitt||Director||Sell||20,000||$19.38||$387,600.00||61,687|| |
|2/28/2014||Holdings Cooperatief U.A. Tmg||Director||Sell||5,125,000||$18.94||$97,067,500.00|| |
|2/27/2014||Richard Wallman||Director||Buy||5,000||$19.28||$96,400.00||58,095|| |
|1/23/2014||Oepw, Llc||major shareholder||Sell||3,015,191||$30.51||$91,993,477.41|| |
|1/15/2014||Jennifer Walker||SVP||Sell||6,050||$32.00||$193,600.00||36,210|| |
|1/8/2014||Eric Stookey||Insider||Sell||8,473||$31.11||$263,595.03||83,668|| |
|11/22/2013||Kyle Joines||VP||Sell||8,310||$30.01||$249,383.10||9,404|| |
|11/20/2013||Jennifer Walker||SVP||Sell||24,999||$29.53||$738,220.47||36,777|| |
|6/5/2013||Edward A Steiger||VP||Sell||2,729||$24.75||$67,542.75|| |
|6/5/2013||Jennifer S Walker||SVP||Sell||1,537||$24.80||$38,117.60|| |
|6/5/2013||Lance A Berry||CFO||Sell||4,816||$24.65||$118,714.40|| |
|6/5/2013||Timothy E Davis Jr||Insider||Sell||3,585||$24.73||$88,657.05|| |
Wright Medical Group (NASDAQ WMGI) News Headlines
Wright Medical Group (NASDAQ:WMGI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Wright Medical Group (NASDAQ:WMGI) Income Statement, Balance Sheet and Cash Flow Statement
Wright Medical Group (NASDAQ WMGI) Stock Chart for Tuesday, February, 20, 2018